CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML

CMV-specific cellular therapy for acute myeloid leukemia?

(2012) K. J. Thomson et al.   BLOOD

CMV: when bad viruses turn good

(2011) A. J. Barrett   BLOOD

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

(2011) A. H. Elmaagacli et al.   BLOOD

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

(2011) F. Milano et al.   BLOOD

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

(2011) M. Della Chiesa et al.   BLOOD

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

(2011) B. Foley et al.   BLOOD

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

(2011) H J Khoury et al.   BONE MARROW TRANSPLANTATION

High Epstein–Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantation

(2011) M Hoegh-Petersen et al.   LEUKEMIA

Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy

(2009) Carolyn E. Behrendt et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION